These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6421474)

  • 1. Kinetics of human light chain synthesis by human-mouse myeloma hybrids.
    Cieplinski W; Wardwell J; Schwink AM
    Cancer Biochem Biophys; 1983 Dec; 7(1):1-10. PubMed ID: 6421474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of amino acid transport by human-mouse myeloma hybrids--difference between human immunoglobulin producers and nonproducers.
    Cieplinski W; Tomicic T; Schwink A; Hajjar J
    Cancer Biochem Biophys; 1985 Feb; 7(4):309-16. PubMed ID: 3978588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic cell hybrids of mouse myeloma cells and B lymphocytes from a patient with agammaglobulinemia: failure to secrete human immunoglobulin.
    Schwaber JF; Rosen FS
    J Immunol; 1979 May; 122(5):1849-54. PubMed ID: 109516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The establishment of a human myeloma cell line elaborating lambda-light chain protein.
    Niho Y; Shibuya T; Yamasaki K; Kimura N
    Int J Cell Cloning; 1984 May; 2(3):161-72. PubMed ID: 6429256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomas.
    Pickering JW; Gelder FB
    J Immunol; 1982 Jul; 129(1):406-12. PubMed ID: 6806365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical typing of human kappa light chain subgroups expressed by human hybrid myelomas.
    Galfrè G; Milstein C
    Immunology; 1982 Jan; 45(1):125-8. PubMed ID: 6799391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mouse myeloma variant with a defect in light chain synthesis.
    Morrison SL; Scharff MD
    Eur J Immunol; 1979 Jun; 9(6):461-5. PubMed ID: 115696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of a new human Bence Jones-type myeloma cell line, NOP-2.
    Nagai T; Ogura M; Morishita Y; Okumura M; Kato Y; Morishima Y; Hirabayashi N; Ohno R; Saito H
    Int J Hematol; 1991 Apr; 54(2):141-9. PubMed ID: 1747447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrangement of lambda light chain genes in mutant clones of the MOPC 315 mouse myeloma cells.
    Hozumi N; Wu G; Murialdo H; Baumal R; Mosmann T; Winberry L; Marks A
    J Immunol; 1982 Jul; 129(1):260-6. PubMed ID: 6806362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines.
    Köhler G; Howe SC; Milstein C
    Eur J Immunol; 1976 Apr; 6(4):292-5. PubMed ID: 825374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
    Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM
    Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary adenylate cyclase-activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cells.
    Li M; Cortez S; Nakamachi T; Batuman V; Arimura A
    Cancer Res; 2006 Sep; 66(17):8796-803. PubMed ID: 16951196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta/lambda type immunoglobulin.
    Matsuo Y; Drexler HG; Harashima A; Okochi A; Hasegawa A; Kojima K; Orita K
    Leuk Res; 2004 Aug; 28(8):869-77. PubMed ID: 15203285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of immunoglobulin by substrate attached mouse myeloma cells.
    Bargellesi A; Damiani G; Kuehl WM; Scharff MD
    J Cell Physiol; 1976 Jun; 88(2):247-51. PubMed ID: 818094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid accumulation in mouse-human parental hybrid cells.
    Cieplinski W; Tomicic T; Hajjar JJ
    Cancer Biochem Biophys; 1983; 6(3):143-7. PubMed ID: 6850550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human endothelial culture supernatant (HECS): evidence for a growth-promoting factor binding to hybridoma and myeloma cells.
    Astaldi GC; Janssen MC; Lansdorp PM; Zeijlemaker WP; Willems C
    J Immunol; 1981 Mar; 126(3):1170-3. PubMed ID: 7462629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the teratocarcinoma phenotype in hybrids between totipotent mouse teratocarcinoma and myeloma cells.
    Correani A; Croce CM
    J Cell Physiol; 1980 Oct; 105(1):73-9. PubMed ID: 7430268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human myeloma cell line suitable for the generation of human monoclonal antibodies.
    Karpas A; Dremucheva A; Czepulkowski BH
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1799-804. PubMed ID: 11172031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of rabbit-mouse hybridomas secreting rabbit immunoglobulin chains.
    Yarmush ML; Gates FT; Weisfogel DR; Kindt TJ
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2899-903. PubMed ID: 6771762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.